On May 30, 2025, Goldman Sachs initiated coverage on Insulet Corporation (PODD, Financial), assigning a "Buy" rating to the stock. The coverage initiation was spearheaded by analyst David Roman, who announced a price target of $380.00 USD for (PODD).
This move marks a significant development for Insulet, as it reflects Goldman Sachs' positive outlook on the company's performance and growth potential. The coverage initiation comes without a prior price target or rating, providing fresh insight into the stock's valuation from one of the most respected financial institutions.
The price target announcement underscores analyst David Roman's confidence in Insulet's future prospects, positioning the company at a promising valuation. Investors and market participants will be watching closely to see how Insulet (PODD, Financial) performs in alignment with this newly announced target.
Wall Street Analysts Forecast
Based on the one-year price targets offered by 23 analysts, the average target price for Insulet Corp (PODD, Financial) is $334.53 with a high estimate of $380.00 and a low estimate of $261.11. The average target implies an upside of 3.08% from the current price of $324.55. More detailed estimate data can be found on the Insulet Corp (PODD) Forecast page.
Based on the consensus recommendation from 25 brokerage firms, Insulet Corp's (PODD, Financial) average brokerage recommendation is currently 1.7, indicating "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
Based on GuruFocus estimates, the estimated GF Value for Insulet Corp (PODD, Financial) in one year is $370.74, suggesting a upside of 14.23% from the current price of $324.545. GF Value is GuruFocus' estimate of the fair value that the stock should be traded at. It is calculated based on the historical multiples the stock has traded at previously, as well as past business growth and the future estimates of the business' performance. More detailed data can be found on the Insulet Corp (PODD) Summary page.